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INTRODUCTION
Ovarian cancer accounts for approximately 3% of
all cancer occurring in women. The prevalence is
relatively stable since 1992.1 The main spread of
ovarian cancer is through the trans-coelomicpath
therefore it often involves abdominal viscera,
peritoneum and omentum.2,3 The omentum of
early stage ovarian cancer patient often times don’t
appear to have macroscopic lesions, yet FIGO
stated that omentectomy need to be performed for
adequate surgery for all stages.4 The role of
omentectomy as a therapeutical modality for early
stage ovarian cancer cannot be concluded.4 The
function of omentum is mainly as a defense against
infection, omentum can also be used for various
surgical procedure, be it in general surgery
or gynecologic surgeries.5-8 Complication of
omentectomy may increase the risk of developing
organ injury such as intestines, spleen and
bleeding.9,10 Vinokurov found that the prevalence
of omental metastases in all stages of ovarian
cancer is 73.9%.11 Terauchi stated that the
prevalence of omental metastases was 47%
(9/19 subjects), indicating that omentum is one
of the major spread locations of ovarian cancer,
and omentectomy should be performed if
possible.12 Those studies didn’t specifically explain
the omentum condition or the stage of ovarian
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Objective: Studies regarding omentectomy on epithelial
ovarian cancer are scarce with conflicting results; this study is
aimed to investigate the prevalence of occult metastases in
patients with epithelial ovarian cancer of the omentum.
Methods: A cross-sectional study design was used by evaluating the
medical records of surgically staged ovarian cancer patients in Dr.
Cipto Mangunkusumo Hospital, Jakarta, Indonesia during the period
of January 2009 to December 2015.
Results: A total of 51 subjects were involved in this study. One
(2%) of 51 subjects was found to have occult metastases in the
omentum. The prevalence of metastases of early stage epithelial
ovarian cancer in 2009-2015 is 33.3% (17 out of 51 subjects),
whereas the omental involvement is found only in 2% subjects
(1 out of 51).
Conclusion: The prevalence of occult metastases of early stage
epithelial ovarian cancer in Dr. Cipto Mangunkusumo Hospital,
Jakarta, Indonesia, from 2009-2015 in 2% (1/51 subjects).
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Abstrak
Tujuan: Mengenai omentektomi dalam pembedahan kanker
ovarium epitelial masih sangat terbatas dengan hasil yang ber-
variasi sehingga dilakukan penelitian ini di Rumah Sakit Dr.
Cipto Mangunkusumo (RSCM).
Metode: Penelitian ini menggunakan desain potong silang dengan
mengambil rekam medis pasien kanker ovarium yang dilakukan pem-
bedahan di RSCM pada bulan Januari 2009 - Desember 2015.
Hasil: Sebanyak 1 subjek dari 51 subjek penelitian (2%) ditemukan
occult metastasis pada omentum. Kejadian metastasis pada kanker
ovarium epithelial stadium dini pada tahun 2009 - 2015 adalah se-
besar 33,3% (17 dari 51 subjek), di mana keterlibatan omentum
ditemukan pada 2% subjek (1 dari 51).
Kesimpulan: Kejadian occult metastasis kanker ovarium epithelial
stadium klinis dini yang dilakukan pembedahan di RSCM tahun
2009 - 2015 adalah sebesar 2% (1 dari 51 subjek).
[Maj Obstet Ginekol Indones 2018; 6-2: 119-122]
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cancer when the surgery performed. Other sources
stated that the prevalence of occult metastases of
epithelial ovarian cancer in omentum varied from
0 to 13%.4,13-15 Studies regarding omentectomy in
epithelial ovarian cancer surgery are scant, and the
results were contradictory. We aim to investigate
the prevalence of epithelial ovarian cancer in
Indonesia.
METHODS
This study used cross sectional study design. Data
were collected from medical records of patients
diagnosed with ovarian cancer who went to Dr.
Cipto Mangunkusumo Hospital during the period
of January 2009 to December 2015. Data were
taken from the Cancer Registry of Oncology
Gynecology of Obstetric and Gynecological
Department of Dr. Cipto Mangunkusumo Hospital,
Faculty Medicine - Universitas Indonesia. Inclusion
criteria were women who were diagnosed with
ovarian cancer and had undergone surgical
staging. Those who underwent surgery without
omentectomy, those who had clinically advanced
ovarian cancer, and patients with pathological
results non-epithelial or incomplete data.
RESULTS
Subject’s characteristics
A total of 401 subjects were recruited in this study.
Of these, 120 were of epithelial ovarian cancer with
primary surgery, and 105 were those who under-
went omentectomy. Of these, 51 cases were found
with early stage.
Table 1. Characteristics of Subjects
Characteristics n %
Clinical Stage
Stage 1 41 80.4
Stage 2 10 19.6
Histopathology Stage
Stage 1 35 68.6
Stage 2 7 13.7
Stage 3 8 15.7
Stage 4 1 2
Subtype
Clearcell 19 37.2
Endometrioid 10 19.6
Mucinous 9 17.7
Serous 13 25.5
Omentum Pathology
Negative 50 98
Positive 1 2
Macroscopic appearance of omentum
Normal 51 100
Grade
N/A 8 15.7
Low grade 14 27.4
Moderate 13 25.5
High grade 16 31.4
Table 2. Prevalence of Metastases of Epithelial Ovarian
Cancer in RSCM from 2009-2015
n %
Metastases No (-) 34 66.7
Yes (+) 17 33.3
Total 51 100.0
Out of 51 subjects of early stage epithelial
ovarian cancer, we found 17 from 51 patients with
positive metastases (33.3%) on uterus, omentum,
appendix, lymph nodes, or cytology. Therefore
prevalence of early stage epithelial ovarian cancer
in RSCM from 2009-2015 is 33.3% (17/51). From
51 clinically early stage epithelial ovarian cancer in
RSCM from 2009-2015, we found 16 cases that
experienced upstaging from histopathological
examination and 35 cases remained as early stage
(31.3% and 68.7%)
Table 3. Prevalence of Omental Occult Metastases of 
Epithelial Ovarian Cancer
Macroscopic Histopathology n %
No macroscopic Negative (-) 50 98
anomaly Positive (+) 1 2
Total 51 100.0
Prevalence of occult metastases of early stage
epithelial ovarian cancer in omentum in RSCM
from 2009-2015 is 2% (1/51), the subject is clini-
cally stage 2.
DISCUSSION
Prevalence of early stage epithelial ovarian
cancer  metastases  in  RSCM  from  2009  ­
2015
Out of 51 early stage epithelial ovarian cancer, we
found 17 from 51 patients with positive metastases
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(33.3%) in uterus, omentum, appendix, lymph
node or cytology. The prevalence of early stage
epithelial ovarian cancer in RSCM from 2009-2015
is 33.3% (17/51), literature recommend to
perform routine surgical staging and we found
30% of upstaging from early stage ovarian cancer
(stage 1 and stage 2), with omental involvement
around 0-11% cases.5,16,17
Prevalence  of  upstaging  of  epithelial  ova­
rian  cancer  clinically  early  stage  in RSCM
from 2009­2015
From 51 patients with clinically early stage ovarian
cancer in RSCM from 2009-2015, we found 16
cases upstaged from the pathological examination
and 35 cases remain early stage (31.3% and
68.7%.) This result is similar to Garcia Soto et al
who studied epithelial ovarian cancer clinically
early stage who underwent surgical staging with
86 subjects, where 25 out of 86 subjects (29%)
were upstaged.18
Prevalence of occult metastases of epithe­
lial ovarian cancer clinically early stage  to
the omentum
In this study we found occult metastases preva-
lence of epithelial ovarian cancer around 2%
(1/51). From literature we found that the range of
prevalence of occult metastases in the omentum
is around 0-13%. This result is similar to other
studies.16,18-21
Distribution  of  epithelial  ovarian  cancer
metastases  in  omentum  based  on  its  sub­
type
We found that the subject who had metastases in
the omentum were patients with serous subtype,
we didn’t found metastases on other subtypes.
Using Fisher’s exact test we found no correlation
between these two variables (p=0.6). This result is
similar to what Garcia Soto et al found in 2012 that
the histology of ovarian cancer is an independent
variable to metastases.16,18
Distribution  of  epithelial  ovarian  cancer
based on  its grade
We found that the subject with omental metastases
were patients with poorly differentiated tumors.
No metastases to the omentum from patients with
good or moderately differentiated tumors. Using
Fisher’s exact test we found no correlation
between the grade of tumor to the metastases.
This result is contradictory with Ayhan’s results
that grade (p<0.03) is correlated significantly with
the stage of the disease.19
CONCLUSION
The prevalence of occult omental metastases in
early stage epithelial ovarian cancer in Dr. Cipto
Mangunkusumo Hospital during the year of 2009
to 2015 was 2%.
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